Search

No relevant pages have been found.

No relevant news have been found: 2

New drug for inherited breast and ovarian cancers shows promise in early trials

Olaparib, a new type of experimental drug called a PARP inhibitor, has shown promising... al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a... olaparib, breast cancer, ovarian...

New drug may help women with hereditary breast cancer

were given 100mg doses of a new drug called olaparib, while the other half received 400mg doses of the drug. Olaparib is one in a... breast cancer, PARP inhibitors, olaparib...

No centres with the requested content found.